Naidong Weng

Covance (United States)

Papers

2

Total Citations

94

H-Index

2

About

Dr. Naidong Weng is a leading expert in bioanalytical chemistry, specializing in the development of highly sensitive and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for therapeutic drug monitoring and pharmacokinetic studies. His major contributions lie in advancing the quantification of small molecule drugs in complex biological matrices, directly supporting clinical trials and drug safety evaluations. Notably, his foundational work on ribavirin—a critical antiviral agent—resulted in a validated LC-MS/MS method that has been cited over 60 times, underscoring its enduring utility in pharmaceutical research. Dr. Weng further demonstrated his methodological precision by simultaneously measuring hydrocodone and its metabolite hydromorphone in human plasma, a key achievement for opioid pharmacokinetics and forensic toxicology. His rigorous validation protocols and attention to matrix effects have set benchmarks for bioanalytical method development. Through these high-impact studies, Dr. Weng has enabled more accurate dosing, improved understanding of drug metabolism, and enhanced patient safety. His work remains essential reading for researchers in bioanalysis, clinical pharmacology, and mass spectrometry.

Research Focus

Key Achievements

2
H-Index
2
Papers
94
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum
62 citations · 2002
📈 Most Prolific Year: 2002 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Covance (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago